Sig Brokerage, LP A Tyr Pharma Inc Call Options Transaction History
Sig Brokerage, LP
- $3.47 Trillion
- Q3 2025
Call Options
1 transactions
Others Institutions Holding LIFE
# of Institutions
133Shares Held
42.4MCall Options Held
4.77MPut Options Held
5.15M-
Federated Hermes, Inc. Pittsburgh, PA10.5MShares$19.6 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$10.5 Million0.0% of portfolio
-
Ubs Group Ag4.51MShares$8.38 Million0.0% of portfolio
-
State Street Corp Boston, MA4.2MShares$7.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.18MShares$4.05 Million0.0% of portfolio
About aTYR PHARMA INC
- Ticker LIFE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,625,000
- Market Cap $53.2M
- Description
- aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...